Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy.

Richard Dorent(Sorbonne Université), I Gandjbakhch(Sorbonne Université), Patrick Nataf(Hôpital Bichat-Claude-Bernard), E Vaissier(Sorbonne Université), Georges Tedy, Ghoussoub Jj, A Pavie, Bors

PubMed

April 1, 1995

Cited by 10

Related Papers

Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

|European Heart Journal|2008|721

Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry

|European Heart Journal|2010|557

Frequency, Risk Factors, and Outcome of Hyperlactatemia After Cardiac Surgery

|CHEST Journal|2003|408

One year follow-up of the multi-centre European PARTNER transcatheter heart valve study

|European Heart Journal|2010|377

Pacemaker infective endocarditis

|The American Journal of Cardiology|1998|314